Anna Moore is the Director of MSU’s Precision Health Program and assistant dean at the College of Human Medicine. Her research is aimed at developing theranostic agents for imaging and therapy in cancer and diabetes.
Dr. Moore received her undergraduate degree in chemistry from Moscow State University and her Ph.D. in Bioorganic Chemistry from A.N. Bach Institute of Biochemistry, Academy of Sciences in Moscow, Russia. Moore previously worked at Massachusetts General Hospital and Harvard Medical School. She is the founder of TransCode Therapeutics and a member of the World Molecular Imaging Society and the International Society for Magnetic Resonance in Medicine.